Open AccessIntralymphatic Immunotherapy (ILIT) with both grass and birch allergen‐ a randomized controlled trial
Author(s) -
Hellkvist Laila,
Hjalmarsson Eric,
Kumlien Susanna Georén,
Winqvist Ola,
Westin Ulla Petersson,
Cardell Lars Olaf
Publication year - 2015
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-5-s4-p29
Subject(s) - medicine , placebo , allergy , randomized controlled trial , quality of life (healthcare) , allergen immunotherapy , allergen , surgery , gastroenterology , immunology , pathology , alternative medicine , nursing
Background Allergen specific immunotherapy is an effective treatment of allergic rhinitis. It is most commonly administered as repeated subcutaneous injections or as a daily sublingual tablet during 3-5 years. In order to shorten the treatment duration previous studies have evaluated the use of intralymphatic injections (ILIT) with promising results. This study assesses safety and efficacy of ILIT with two allergens given simultaneously.